Ocular Therapeutix Inc Share Price Today: Live Updates & Key Insights
Ocular Therapeutix Inc share price today is $8.21, up -1.09%. The stock opened at $8.295 against the previous close of $8.27, with an intraday high of $8.41 and low of $8.04.
Ocular Therapeutix Inc Share Price Chart
Ocular Therapeutix Inc
Ocular Therapeutix Inc Share Price Performance
Ocular Therapeutix Inc Institutional Holdings
Ocular Therapeutix Inc Market Status
Ocular Therapeutix Inc Fundamentals
Market Cap 1780.72 M
PB Ratio 2.7215
PE Ratio 0.0
Enterprise Value 1120.63 M
Total Assets 808.06 M
Volume 4158496
Ocular Therapeutix Inc Company Financials
About Ocular Therapeutix Inc & investment objective
Company Information Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Organisation Biotechnology
Employees 325
Industry Biotechnology
CEO Dr. Pravin U. Dugel M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Ocular Therapeutix Inc FAQs
What is the share price of Ocular Therapeutix Inc today?
The current share price of Ocular Therapeutix Inc is $8.21.
Can I buy Ocular Therapeutix Inc shares in India?
Yes, Indian investors can buy Ocular Therapeutix Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Ocular Therapeutix Inc shares in India?
You can easily invest in Ocular Therapeutix Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Ocular Therapeutix Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Ocular Therapeutix Inc.
Can I buy fractional shares of Ocular Therapeutix Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Ocular Therapeutix Inc?
Ocular Therapeutix Inc has a market cap of $1780.72 M.
In which sector does Ocular Therapeutix Inc belong?
Ocular Therapeutix Inc operates in the Biotechnology sector.
What documents are required to invest in Ocular Therapeutix Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Ocular Therapeutix Inc?
The PE ratio of Ocular Therapeutix Inc is N/A and the PB ratio is 2.72.